ホーム > 金子新/ Kaneko, Shin

金子新

Kaneko, Shin

iPS細胞研究所増殖分化機構研究部門免疫再生治療分野 , 教授
Regenerative Immunotherapy (Shin Kaneko Lab), Dept. Cell Growth and Differentiation, Center for iPS cell Research and Application (CiRA) , Professor

オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。

1. Current Landscape of Adoptive Cell Therapy and Challenge to Develop "Off-The-Shelf" Therapy for Hepatocellular Carcinoma. Seung Kak Shin; Yuta Mishima; Yoonseok Lee; Oh Sang Kwon (+2 著者) Shin Kaneko
Journal of gastroenterology and hepatology 40: 791 (2025)
2. Development of chimeric antigen receptor T cells targeting cancer-expressing podocalyxin. Yuta Mishima; Shintaro Okada; Akihiro Ishikawa; Bo Wang (+3 著者) Shin Kaneko
Regenerative therapy 28: 292 (2025)
3. Human iPSC-derived CD4+ Treg-like cells engineered with chimeric antigen receptors control GvHD in a xenograft model. Hisashi Yano; Keiko Koga; Takayuki Sato; Tokuyuki Shinohara (+7 著者) Shin Kaneko
Cell stem cell 31: 795 (2024) Semantic Scholar
4. A culture method with berbamine, a plant alkaloid, enhances CAR-T cell efficacy through modulating cellular metabolism. Shin-Ichiro Takayanagi; Sayaka Chuganji; Masahiro Tanaka; Bo Wang (+14 著者) Shin Kaneko
Communications biology 7: 685 (2024) Semantic Scholar
5. Downregulating the immune synapses of iPSC-derived T cells to escape the NK cell-mediated killing(タイトル和訳中) 張静; 王博; 蟹江慶太郎; 吉田宗弘金子新
日本がん免疫学会総会・日本バイオセラピィ学会学術集会総会合同大会プログラム・抄録集 28回・37回: 127 - 127 (2024)
6. Genome editing iPSC to purposing enhancement of induce CD8 killer T cell function for regenerative immunotherapy. Sota Kurihara; Akihiro Ishikawa; Shin Kaneko
Inflammation and regeneration 44: 20 (2024) Semantic Scholar
7. Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8αβ+ T cells targeting multiple myeloma. Jooeun Bae; Shuichi Kitayama; Zach Herbert; Laurence Daheron (+10 著者) Kenneth C Anderson
Blood 143: 895 (2024) Semantic Scholar
8. Effective and stable gene transduction in rhesus macaque iPSCs capable of T-lineage differentiation utilizing the piggyBac system. Masahiro Tanaka; Yoshihiro Iwamoto; Bo Wang; Eri Imai (+2 著者) Shin Kaneko
Regenerative therapy 27: 104 (2024) Semantic Scholar
9. Lineage tracing of T cell differentiation from T-iPSC by 2D feeder-free culture and 3D organoid culture. Yoshitaka Ishiguro; Shoichi Iriguchi; Shinya Asano; Tokuyuki Shinohara (+5 著者) Shin Kaneko
Frontiers in immunology 14: 1303713 (2023) Semantic Scholar
10. Synthetic immune checkpoint engagers protect HLA-deficient iPSCs and derivatives from innate immune cell cytotoxicity Alessia Gravina; Grigol Tediashvili; Yueting Zheng; Kumiko A. Iwabuchi (+6 著者) Tobias Deuse
Cell Stem Cell 30: 1538 (2023) Semantic Scholar
11. Mini-TCRs: Truncated T cell receptors to generate T cells from induced pluripotent stem cells Shin-ichiro Takayanagi; Bo Wang; Saki Hasegawa; Satoshi Nishikawa (+8 著者) Shin Kaneko
Molecular Therapy - Methods & Clinical Development 31: 101109 (2023) Semantic Scholar
12. Humanized mouse models with endogenously developed human natural killer cells for in vivo immunogenicity testing of HLA class I-edited iPSC-derived cells. Charlotte Flahou; Tatsuya Morishima; Natsumi Higashi; Yoshikazu Hayashi (+13 著者) Naoshi Sugimoto
Biochemical and biophysical research communications 662: 76 (2023) Semantic Scholar
13. Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells. Tatsuki Ueda; Sara Shiina; Shoichi Iriguchi; Seitaro Terakura (+15 著者) Shin Kaneko
Nature biomedical engineering 7: 24 (2023) Semantic Scholar
14. Improved anti-solid tumor response by humanized anti-podoplanin chimeric antigen receptor transduced human cytotoxic T cells in an animal model. Akihiro Ishikawa; Masazumi Waseda; Tomoko Ishii; Mika K Kaneko (+1 著者) Shin Kaneko
Genes to cells : devoted to molecular & cellular mechanisms 27: 549 (2022) Semantic Scholar
15. Development of B-cell maturation antigen (BCMA)-specific CD8⁺ cytotoxic T lymphocytes using induced pluripotent stem cell technology for multiple myeloma. Jooeun Bae; Shuichi Kitayama; Zach Herbert; Laurence Daheron (+3 著者) Kenneth Carl Anderson
Journal of Clinical Oncology 40: 2542 - 2542 (2022) Semantic Scholar
16. Sustainable Antiviral Efficacy of Rejuvenated HIV-Specific Cytotoxic T Lymphocytes Generated from Induced Pluripotent Stem Cells. Shoji Miki; Yohei Kawai; Kaori Nakayama-Hosoya; Ryutaro Iwabuchi (+5 著者) Ai Kawana-Tachikawa
Journal of virology 96: e0221721 (2022) Semantic Scholar
17. The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-1derived iPS cells Takeshi Ito; Yohei Kawai; Yutaka Yasui; Shoichi Iriguchi (+7 著者) Shin Kaneko
Communications Biology 4: (2021) Semantic Scholar
18. Induced pluripotent stem cell-derived natural killer cells gene-modified to express chimeric antigen receptor-targeting solid tumors Tatsuki Ueda; Shin Kaneko
International Journal of Hematology 114: 572 (2021) Semantic Scholar
19. Generation of highly proliferative, rejuvenated cytotoxic T cell clones through pluripotency reprogramming for adoptive immunotherapy. Yohei Kawai; Ai Kawana-Tachikawa; Shuichi Kitayama; Tatsuki Ueda (+2 著者) Shin Kaneko
Molecular therapy : the journal of the American Society of Gene Therapy 29: 3027 (2021) Semantic Scholar
20. Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy. Hiroaki Mashima; Rong Zhang; Tsuyoshi Kobayashi; Hirotake Tsukamoto (+10 著者) Yasushi Uemura
Molecular therapy. Methods & clinical development 21: 171 (2021) Semantic Scholar

1 2 3 … 5 »

1. In Vitro Detection of Cellular Adjuvant Properties of Human Invariant Natural Killer T Cells Rong Zhang; Shuichi Kitayama; Tianyi Liu; Norihiro Ueda; Yumi Tokumitsu; Hiroaki Mashima; Hideki Ohdan; Shin Kaneko; Yasushi Uemura (担当:分担執筆)
Humana Press Inc. 2019年
2. In Vitro Differentiation of T Cells: From Human Embryonic Stem Cells and Induced Pluripotent Stem Cells Shoichi Iriguchi; Shin Kaneko (担当:分担執筆)
Humana Press Inc. 2019年
3. Differentiating CD8αβ T Cells from TCR-Transduced iPSCs for Cancer Immunotherapy Atsutaka Minagawa; Shin Kaneko (担当:分担執筆)
Humana Press Inc. 2019年
4. In Vitro Differentiation of T Cells: From Nonhuman Primate-Induced Pluripotent Stem Cells Shoichi Iriguchi; Shin Kaneko (担当:分担執筆)
Humana Press Inc. 2019年
5. In Vitro Differentiation of T Cell: From CAR-Modified T-iPSC Tatsuki Ueda; Shin Kaneko (担当:分担執筆)
Humana Press Inc. 2019年
6. Redifferentiation of Adaptive Naïve-Like CTL from T-Cell-Derived iPSC Yohei Kawai; Shin Kaneko (担当:分担執筆)
Humana Press Inc. 2019年

1. スタートアップから見た創薬～がん免疫治療とiPS細胞金子新
第36回製薬協政策セミナー 2025年3月17日招待有り
2. iPS細胞から誘導したCAR-T細胞療法の開発金子新
Liver Scientific Frontier2025 2025年3月8日招待有り
3. Generation of therapeutics T cells from iPS cells for cancer immunology 金子新
TIB CATAPULT/LINK-BioBAY TOKYO Kick-off Symposium and Lab Tour 2025年2月20日招待有り
4. 自己と非自己、免疫とがん、そして個別化iPS治療 your cancer,your cell,your cure 金子新
Super Cells Infinite 2025年2月11日招待有り
5. ＜CancerX Innovation＞『これまでになかった治療を届けるには』金子新
World Cancer Week 2025 2025年2月2日招待有り
6. Development of Immune CellTherapy using iPS cell Technology 金子新
2024CNU International Symposium on Medical Science（CNU-ISMS） 2024年11月22日招待有り
7. Tackling cancer treatment using iPS cells! 金子新
GASA研修会 2024年11月19日招待有り
8. iPS細胞技術を用いたアロジェニックCAR-T細胞治療の開発金子新
第50回セルセラピーセミナー 2024年11月15日招待有り
9. The generation of T cells from iPSCs for immunotherapy 金子新
1st CCII International Symposium on Immunotherapy and Immunobiology 2024年11月14日招待有り
10. iPS細胞と私たちの生活金子新
神戸市シルバーカレッジ 2024年11月5日招待有り
11. The Generation of T cells from iPS cells for Immunotherapy 金子新
The 33rd Hot Spring Harbor International Symposium − Cutting-Edge Research and Technology in Stem Cells and Reprogramming − 2024年10月29日招待有り
12. Generation of therapeutic immune cells from iPSCs 金子新
第62回日本癌治療学会学術集会 2024年10月25日招待有り
13. iPS 細胞からの免疫細胞再生とその臨床応用に向けて金子新
第227回茨城県内科学会 2024年10月20日招待有り
14. 培養をデザインしてiPS免疫細胞を誘導する金子新
幹細胞の培養法・培養工学のためのコンソーシアム第8回シンポジウム 2024年10月19日招待有り
15. 同種iPS細胞を用いた癌免疫療法の開発金子新
第9回肺癌バイオカンファレンス 2024年10月5日招待有り
16. GPC３ CAR発現iPS細胞由来ILC/NK細胞の患者体内生存延長と抗腫瘍エフェクター機能向上を目指したリバーストランスレーショナル研究金子新
令和6年度AMED再生・細胞医療・遺伝子治療プロジェクト研究交流会 2024年9月30日招待有り
17. iPS細胞を用いたCAR-T細胞、CAR-NK細胞療法の開発 ShinKaneko
第83回日本癌学会学術総会 2024年9月21日招待有り
18. iPS細胞技術を用いた免疫細胞治療の開発金子新
シンポジウム：細胞治療薬開発研究におけるin vivo 実験モデルの果たす役割 2024年9月18日招待有り
19. iPSC-derived cells
3rd Translational Research Conference: Immune & Cellular Therapies 2024年9月13日招待有り
20. ｉＰＳ細胞を使った最先端のがん治療研究～万能細胞で挑む免疫治療～金子新
海上自衛隊舞鶴地方総監部主催特別講演会 2024年8月30日招待有り